• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡马西平及其环氧和羟基代谢物在人体过量服用后的临床药代动力学。

Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.

作者信息

Vree T B, Janssen T J, Hekster Y A, Termond E F, van de Dries A C, Wijnands W J

出版信息

Ther Drug Monit. 1986;8(3):297-304. doi: 10.1097/00007691-198609000-00011.

DOI:10.1097/00007691-198609000-00011
PMID:3750374
Abstract

In five cases of carbamazepine (CBZ) intoxication, the time curves of the plasma concentration and of the renal excretion rate of carbamazepine and its metabolites carbamazepine 10,11-epoxide (CBZ-epoxide) and trans-10,11-dihydro-10,11-dihydroxy-CBZ (CBZ-diol) were measured. Pseudo-steady-state or plateau-like plasma concentration-time curves were observed when doses of 12 or 18 g of CBZ were ingested. Hemoperfusion lowers the plasma concentration of CBZ and its metabolites by affecting the half-life. The effect of hemoperfusion is reduced by the continuous absorption from the gastrointestinal tract and redistribution from the tissues. The renal clearances of CBZ and of CBZ-epoxide are low (1 and 8 ml/min, respectively); both are flow dependent. The renal clearance of CBZ-diol is approximately 160-350 ml/min and is independent of the urine flow. Although urine stimulation increases the renal clearance of CBZ by 100%, the overall amount excreted increases only 1-2% of the dose. Protein binding of CBZ is approximately 80%, of CBZ-epoxide 50%, and of CBZ-diol 70%.

摘要

在5例卡马西平(CBZ)中毒病例中,测定了卡马西平及其代谢产物卡马西平10,11 - 环氧化物(CBZ - 环氧化物)和反式 - 10,11 - 二氢 - 10,11 - 二羟基 - 卡马西平(CBZ - 二醇)的血浆浓度时间曲线和肾脏排泄率时间曲线。当摄入12克或18克卡马西平时,观察到了伪稳态或类似平台的血浆浓度 - 时间曲线。血液灌流通过影响半衰期降低了卡马西平及其代谢产物的血浆浓度。胃肠道的持续吸收和组织的再分布降低了血液灌流的效果。卡马西平和CBZ - 环氧化物的肾脏清除率较低(分别为1和8毫升/分钟);两者均与血流有关。CBZ - 二醇的肾脏清除率约为160 - 350毫升/分钟,且与尿流无关。尽管尿液刺激使卡马西平的肾脏清除率提高了100%,但排泄的总量仅增加了剂量的1 - 2%。卡马西平的蛋白结合率约为80%,CBZ - 环氧化物为50%,CBZ - 二醇为70%。

相似文献

1
Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.卡马西平及其环氧和羟基代谢物在人体过量服用后的临床药代动力学。
Ther Drug Monit. 1986;8(3):297-304. doi: 10.1097/00007691-198609000-00011.
2
Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.卡马西平治疗成人和儿童期间卡马西平 -10,11 -二醇的稳态血清水平及肾脏排泄情况
Ther Drug Monit. 1984;6(3):259-65. doi: 10.1097/00007691-198409000-00001.
3
Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.卡马西平-10,11-环氧化物的单剂量动力学与代谢
Clin Pharmacol Ther. 1983 Jan;33(1):58-65. doi: 10.1038/clpt.1983.8.
4
Early stage autoinduction of carbamazepine metabolism in humans.人类体内卡马西平代谢的早期自动诱导
Eur J Clin Pharmacol. 1994;47(4):355-60. doi: 10.1007/BF00191168.
5
Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.人类体内的卡马西平代谢。诱导作用及药物遗传学方面。
Clin Pharmacokinet. 1985 Jan-Feb;10(1):80-90. doi: 10.2165/00003088-198510010-00004.
6
Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.卡马西平及其主要代谢产物的自动诱导和稳态药代动力学
Br J Clin Pharmacol. 1992 Jun;33(6):611-5. doi: 10.1111/j.1365-2125.1992.tb04089.x.
7
Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.卡马西平的活性代谢物卡马西平-10,11-环氧化物肠溶制剂的单剂量动力学。
Ther Drug Monit. 1988;10(4):382-5.
8
Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.癫痫患儿中卡马西平及其代谢物稳态血浆浓度的每日变化。
Clin Pharmacokinet. 1991 Mar;20(3):237-46. doi: 10.2165/00003088-199120030-00005.
9
Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning.血液灌流治疗两例急性卡马西平中毒
J Toxicol Clin Toxicol. 1984;22(4):349-62. doi: 10.3109/15563658408992566.
10
Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.在一次大量服药过量的连续静脉-静脉血液滤过过程中对卡马西平和卡马西平-10,11-环氧化物清除率的测定。
Clin Toxicol (Phila). 2016 Jun;54(5):424-7. doi: 10.3109/15563650.2016.1148721. Epub 2016 Mar 4.

引用本文的文献

1
Management of acute carbamazepine poisoning: A narrative review.急性卡马西平中毒的管理:一项叙述性综述。
World J Psychiatry. 2023 Nov 19;13(11):816-830. doi: 10.5498/wjp.v13.i11.816.
2
Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach.CYP3A4和CYP2B6诱导剂卡马西平的药代动力学及其药物相互作用潜力:基于生理的药代动力学建模方法
Pharmaceutics. 2021 Feb 17;13(2):270. doi: 10.3390/pharmaceutics13020270.
3
Combination Clearance Therapy and Barbiturate Coma for Severe Carbamazepine Overdose.
联合清除疗法及巴比妥酸盐昏迷疗法用于严重卡马西平过量中毒治疗
Pediatrics. 2017 May;139(5). doi: 10.1542/peds.2016-1560.
4
Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup.体外治疗卡马西平中毒:EXTRIP 工作组的系统评价和建议。
Clin Toxicol (Phila). 2014 Dec;52(10):993-1004. doi: 10.3109/15563650.2014.973572. Epub 2014 Oct 30.
5
Successful treatment of severe carbamazepine toxicity with 5% albumin-enhanced continuous venovenous hemodialysis.采用5%白蛋白强化连续性静脉-静脉血液透析成功治疗严重卡马西平中毒。
J Artif Organs. 2014 Jun;17(2):206-9. doi: 10.1007/s10047-014-0754-4. Epub 2014 Jan 22.
6
Clinical toxicology.临床毒理学
Postgrad Med J. 1993 Jan;69(807):19-32. doi: 10.1136/pgmj.69.807.19.
7
Signs and symptoms of carbamazepine overdose.卡马西平过量的体征和症状。
J Neurol. 1995 Feb;242(3):169-73. doi: 10.1007/BF00936891.
8
Controlled release drugs in overdose. Clinical considerations.过量服用的控释药物。临床考量。
Drug Saf. 1995 Jan;12(1):73-84. doi: 10.2165/00002018-199512010-00006.
9
Carbamazepine toxicity and poisoning. Incidence, clinical features and management.卡马西平毒性与中毒。发病率、临床特征及处理
Med Toxicol Adverse Drug Exp. 1989 Mar-Apr;4(2):95-107. doi: 10.1007/BF03259906.
10
Pharmacokinetic optimisation of anticonvulsant therapy.抗惊厥治疗的药代动力学优化
Clin Pharmacokinet. 1992 Sep;23(3):216-30. doi: 10.2165/00003088-199223030-00004.